# A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

> **NCT03809325** · — · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 225 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone Palmitate 3-Month Formulation (PP3M)

## Key facts

- **NCT ID:** NCT03809325
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-21
- **Primary completion:** 2019-07-12
- **Final completion:** 2019-07-12
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809325, "A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03809325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*